Lv41
630 积分 2026-02-26 加入
Greater Placebo Effect in Topical Than in Systemic Therapies for Androgenetic Alopecia: A Systematic Review and Meta-Analysis
2天前
已关闭
Greater Placebo Effect in Topical Than in Systemic Therapies for Androgenetic Alopecia: A Systematic Review and Meta-Analysis
2天前
已完结
Acquired causes of eyebrow and eyelash loss: A review and approach to diagnosis and treatment
1个月前
已完结
The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment
2个月前
已完结
500 - Patient-reported outcomes following 24 weeks of treatment with upadacitinib in adults with non-segmental vitiligo: results from a phase 2, randomized, double-blind, dose-ranging study
5个月前
已完结
Oral tofacitinib in comparison with dexamethasone oral mini-pulse therapy for the treatment of active nonsegmental vitiligo: A randomized controlled trial
5个月前
已完结
501 - Efficacy and safety of upadacitinib in a phase 2 randomized, double-blind, dose-ranging study of adults with extensive non-segmental vitiligo
5个月前
已完结
Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, stabilizes active lesions and promotes re-pigmentation of stable lesions in patients with active nonsegmental vitiligo: results from a phase 2b, randomized, placebo-controlled, dose-ranging study
5个月前
已关闭
721 - Efficacy and safety of povorcitinib for extensive vitiligo: 52-week results from a double-blinded, placebo-controlled, dose-ranging phase 2b study
5个月前
已完结
Comparative efficacy of topical tofacitinib versus topical tacrolimus in the treatment of localized vitiligo: a randomized investigator-blinded intraindividual trial
6个月前
已完结
皖公网安备34019202002308
